Camden Partners

Camden Partners is a United States-based investment firm founded in 1995 and based in the Baltimore, Maryland area. It acts as an asset manager providing growth and private equity capital to lower-middle-market companies, primarily in technology, software, education, healthcare, and business services. The firm pursues early to growth-stage investments across North America and Western Europe, applying sector knowledge and active involvement to help portfolio companies scale. Camden Partners emphasizes disciplined, fundamentals-driven approach and seeks long-term partnerships with management teams and other investors, including board-level engagement where appropriate. The company operates as a registered investment adviser and focuses on building lasting value through strategic capital and advisory support.

Meghan J. McGuire

Principal

J. Todd Sherman

Managing Partner

David Warnock

Founder, Partner and Member of the Investment Committee

Past deals in Maryland

Catalyte

Convertible Note in 2019
Catalyte discovers high-potential talent using AI, develops them through paid apprenticeships, and deploys them directly into client organizations. This approach boosts productivity, quality, and diversity in its clients' workforces.

Thrive Earlier Detection

Series A in 2019
Thrive Earlier Detection is a healthcare company dedicated to saving lives through early detection of cancer. It develops CancerSEEK, a liquid biopsy test designed to identify various cancers in their earliest stages via blood analysis.

WindMIL Therapeutics

Series B in 2018
WindMIL Therapeutics, Inc. is a biotechnology company focused on developing innovative cell therapies for cancer treatment. Established in 2015 and based in Baltimore, Maryland, the company specializes in translating insights from bone marrow immunology into effective therapeutic solutions. WindMIL Therapeutics utilizes its proprietary platform to create a new class of cell therapies known as Marrow Infiltrating Lymphocytes (MILs), which are derived from memory T cells found in the bone marrow. These therapies leverage re-activated T-cells that are typically dormant, harnessing the unique immunologic properties of the bone marrow to enhance cancer immunotherapy. Through its advancements, WindMIL Therapeutics aims to provide life-saving treatments for cancer patients, addressing a critical need in oncology.

Blispay

Venture Round in 2017
Blispay Inc. is a financial technology company based in Baltimore, Maryland, founded in 2014. It develops a mobile application designed for online bill payments and provides a unique financing solution for retailers through its Blispay Visa Card. This mobile-centric credit card allows merchants, regardless of size, to offer a streamlined in-store financing experience without the need for technical integration or financial commitments. Customers benefit from instant card issuance, six months of special financing options, and 2% cash back on purchases. Blispay aims to enhance the shopping experience by providing everyday credit and financing solutions that cater to the needs of both consumers and small to midsize retailers, ultimately helping businesses increase sales and improve customer satisfaction. The founding team comprises seasoned professionals with backgrounds at notable companies including PayPal and Microsoft.

Paragon Bioservices

Series A in 2014
Paragon Bioservices, Inc. is a contract development and manufacturing organization headquartered in Baltimore, Maryland, specializing in the development and production of biopharmaceuticals. The company focuses on a range of advanced therapeutic products, including viral vector-based gene therapies, next-generation vaccines, monoclonal antibodies, and recombinant proteins. Paragon offers comprehensive services that encompass process and analytical development, as well as cGMP manufacturing and testing for pre-clinical and early clinical stages. With a commitment to innovation, Paragon has transitioned its client base from primarily government contracts to a strong emphasis on commercial partnerships within the biotech industry. The company's leadership team, composed of experienced professionals with over 20 years in the field, supports its mission to deliver high-quality manufacturing solutions. Paragon operates from a state-of-the-art facility that spans 150,000 square feet, providing the infrastructure necessary for the complete lifecycle of biopharmaceutical manufacturing, from initial development through to commercial launch.

Calvert Learning

Series A in 2013
Calvert Learning, formerly known as Calvert Education Services, LLC, specializes in providing a comprehensive homeschool curriculum that integrates traditional textbooks with online learning. Founded in 1906 and based in Hunt Valley, Maryland, the company offers a wide range of courses including history, mathematics, science, foreign languages, and arts, catering to English-speaking students from pre-kindergarten to eighth grade globally. Calvert Learning also operates virtual and distance learning programs and provides advisory teaching and technical support services. With over a century of experience, the organization focuses on delivering high-quality education tailored to the unique needs of students in nontraditional learning settings. While its curriculum and tools are now primarily offered through school partnerships, Calvert remains committed to supporting homeschool families by ensuring access to its trusted educational resources.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.